1. Home
  2. EYE vs NUVB Comparison

EYE vs NUVB Comparison

Compare EYE & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$18.65

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.58

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYE
NUVB
Founded
1990
2018
Country
United States
United States
Employees
N/A
305
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
EYE
NUVB
Price
$18.65
$4.58
Analyst Decision
Buy
Strong Buy
Analyst Count
12
13
Target Price
★ $28.18
$13.00
AVG Volume (30 Days)
1.4M
★ 5.0M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 202.78
71.56
EPS
★ 0.54
N/A
Revenue
★ $1,987,488,000.00
$62,902,000.00
Revenue This Year
$3.58
$211.79
Revenue Next Year
$5.10
$45.15
P/E Ratio
$34.81
★ N/A
Revenue Growth
9.00
★ 698.96
52 Week Low
$14.75
$3.92
52 Week High
$30.02
$9.75

Technical Indicators

Market Signals
Indicator
EYE
NUVB
Relative Strength Index (RSI) 65.35 33.93
Support Level $16.02 $4.10
Resistance Level $19.18 $5.16
Average True Range (ATR) 0.61 0.24
MACD 0.25 0.03
Stochastic Oscillator 88.48 33.57

Price Performance

Historical Comparison
EYE
NUVB

About EYE National Vision Holdings Inc.

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: